![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Adis International Limited
Publisher: Adis International
ISSN: 1172-0360
Source: Drugs & Therapy Perspectives, Vol.22, Iss.2, 2006-01, pp. : 5-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Palifermin: In Myelotoxic Therapy-Induced Oral Mucositis
By Siddiqui M. Asif A. Wellington Keri
Drugs, Vol. 65, Iss. 15, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Palifermin: Painful oral mucosal hyperpigmentation, rash and tongue thickness: case report
Reactions Weekly, Vol. 1, Iss. 1332, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Methotrexate: Oral mucositis in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Benzydamine is effective for the prophylaxis of radiation-induced oral mucositis
Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. :